CATHERINE SLUSSER: Open Payments
NPI 1255176657 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: JARDIANCE, VERQUVO, AMVUTTRA, LEQVIO, LifeVest, CAPVAXIVE, Kerendia, FUROSCIX.
Industry payments across MI — which companies pay providers there.
